No intervention
Otherno difference: both cohorts are followed in the same way
NCT Number: NCT06649032
The purpose of this study is to acquire reliable and current data on the actual incidence (post-COVID) of respiratory tract infections in the general adult population in the absence of any intervention. These data will provide useful background information for designing future studies aimed at assessing whether preventive measures or pharmacological treatments are beneficial in reducing the frequency and severity of infectious episodes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dr F Pugliese, Bari, Italy
This multicentric prospective observational survey will be carried out in Italy during the winter and early spring ( December 22nd to April 30th) in two consecutive years on approximately 2750 subjects recruited in the period between November 1st and December 21st in different medical settings and regions.
Investigators from 4 different institutions will be involved:
FIMMG (Federazione Italiana dei Medici di Medicina Generale). Ten general practitioners will recruit approx. 1000 consecutive subjects from the general population.
SIAAIC (Societa' Italiana di Allergologia, Asma e Immunologia Clkinica). Ten allergy specialists will recruit approx.1000 consecutive subjects suffering from allergic diseases.
Fondazione Maugeri (5 Centers) and UCSC (Universita' Cattolica del Sacro Cuore) / Policlinico Gemelli will recruit approx. 750 consecutive subjects suffering from asthma or COPD.
Participants having signed an informed consent at any suspected Respiratory Tract Infection (RTI) during the observation period will be asked to contact (phone call or visit) the investigator to record the relevant clinical information documenting the RTI episode.
At the end of the observation period all subjects will be contacted by the investigators to check for completeness and compliance of the RTI reporting.
The procedure will be repeated in the same way in the second year of survey but including subjects having experienced at least one confirmed RTI during the first year. This will allow assessing intra-individual variability of infectious episodes from year to year.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male or female aged from at least 18 years -
Exclusion criteria
Minor subjects-
no difference: both cohorts are followed in the same way
Time frame: From 22nd Dec 2023 to 30th Apr2024 and from 22nd Dec 2024 to 30th Apr 2025
Overall mean number of respiratory tract infections during both observation periods (whole period), mean number of respiratory tract infections for subjects with or without risk factors during the whole period.
Time frame: from 22nd Dec 2023 to 30th Apr 2024
Time frame: from 22nd Dec 2024 to 30th Apr 2025
Time frame: From 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024
Time frame: from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024
Time frame: from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024
Time frame: from 22nd Dec 2024 to 30th Apr 2025
Time frame: 023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025 from 22nd Dec 2
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024
Time frame: from 22nd Dec 2024 to 30th Apr 2025
Time frame: from 22nd Dec 2023 to 30th Apr 2024 and from 22nd Dec 2024 to 30th Apr 2025
Lallemand Pharma AG
Industry
A Multicentric Epidemiological Study of the Actual Incidence of Respiratory Tract Infections in an Adult Italian Population, With or Without Underlying Risk Factors
Acronym: SIRTI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695441
Healthy Adults, Postprandial Glycemic Response
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT07454551
Healthy Adults, Young
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05379101
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Rochester, Minnesota, United States
View Trial DetailsNCT07636018
Healthy Adults
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial Details